Turn your product vision into venture capital

Is your asset investor-ready?

Securing early-stage funding isn’t just about the science — it’s about telling a compelling, value-driven story that resonates with investors.

This IQVIA Biotech Insight Brief offers practical tools to help you:

Build a credible Target Product Profile (TPP)
Design a strategic Clinical Development Plan (CDP)
Quantify asset value using Expected Net Present Value (eNPV)

Learn how to de-risk your development strategy, align stakeholders and showcase the full commercial potential of your lead asset — whether you're preparing for Series A or your next pitch.

DOWNLOAD: De-Risking Early-Stage Biotech: Turning Vision into Venture Capital

Fill out the form to download the insight brief

First Name *

Last Name *

Business Email *

Job Title *

Company *

Country *

Opt In

By selecting this box, I consent to receive communications about IQVIA's offering by email.

We listen, you succeed, lives improve. Let us know how we can support your clinical development program, bring your innovation to market and maximize patient impact.

address1

DO NOT SELL MY PERSONAL INFORMATION